Dalcetrapib
id:
dalcetrapib-283-2658723
title:
Dalcetrapib
text:
Dalcetrapib (INN, codenamed JTT-705) is a CETP inhibitor which was being developed by Hoffmann–La Roche until May 2012. The drug was aimed at raising the blood levels of HDL cholesterol. Prevailing observations indicate that high HDL levels correlate with better overall cardiovascular health, though it remains unclear whether raising HDL levels consequently leads to an increase in cardiovascular health. A 24-week clinical trial showed that dalcetrapib did increase HDL-C levels, supporting the ag
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dalcetrapib
date created:
date modified:
2024-03-11T04:52:35Z
main entity:
{"identifier":"Q5210285","url":"https://www.wikidata.org/entity/Q5210285"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/10/Dalcetrapib.svg","width":512,"height":324}
fields total:
13
integrity:
15